I think the point is that insurances might not pay for the better options as willingly as they do now if there’s a cheaper option. But I understand too little of the US healthcare system to be completely sure.
The problems aren’t the treatments, the problems are still the assholes pricing the treatments that exacerbate issues with treatment affordability and selection.
I think the point is that insurances might not pay for the better options as willingly as they do now if there’s a cheaper option. But I understand too little of the US healthcare system to be completely sure.
The problems aren’t the treatments, the problems are still the assholes pricing the treatments that exacerbate issues with treatment affordability and selection.